Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of LUMO will rise by +0.27% over the next 2 Weeks and hit $4.35 by Friday, December 27, 2024. In that time frame, LUMO's share price is expected to range between $4.32 and $4.38.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Dec 27, 2024 | 4.32 | 4.35 | 4.38 |
| Dec 26, 2024 | 4.33 | 4.36 | 4.39 |
| Dec 25, 2024 | 4.31 | 4.33 | 4.36 |
| Dec 24, 2024 | 4.34 | 4.36 | 4.39 |
| Dec 23, 2024 | 4.35 | 4.38 | 4.40 |
| Dec 20, 2024 | 4.32 | 4.34 | 4.37 |
| Dec 19, 2024 | 4.33 | 4.35 | 4.38 |
| Dec 18, 2024 | 4.30 | 4.32 | 4.35 |
| Dec 17, 2024 | 4.33 | 4.36 | 4.38 |
| Dec 16, 2024 | 4.34 | 4.37 | 4.40 |
LUMO shares remained flat 0 in Wednesday, December 11, 2024's trading session, starting and closing at a previous close of $4.34 to move at $4.34. The stock demonstrated notable intraday movement (see LUMO's key stats for a full breakdown), fluctuating between $4.33 and $4.34, a +0.23% trading range. While recent weeks have seen some volatility, LUMO has managed to secure a -0.91% drop over the past 2 weeks. The neutral price movement was accompanied by remained steady trading volume, with approximately 0 shares changing hands, 0 fewer than the previous session. This amounted to $0.00 in total market activity.
Will LUMO Continue Its Upward Trend?
According to analyst ratings and projections for LUMO, Lumos Pharma, Inc. shares are anticipated to increase by +0.92%, potentially reaching $4.38 per share by December 27, 2024. Short-term technical indicators currently suggest a neutral sentiment for LUMO. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 11 positive trading days within the past 30 sessions. Based on the LUMO stock forecast, now is a good time to buy LUMO stock because its current trading price is -0.27% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on LUMO covering social and institutional perspectives.
LUMO Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into LUMO's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 54.51% to 56.75%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 57.66%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 55.30%, maintains a neutral outlook for the long term. Insights into LUMO's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Lumos Pharma, Inc. Monthly Forecast 2024–2025
December 2024
According to our latest forecast models, Lumos Pharma, Inc. (LUMO) is positioned to show a strong performance in December 2024. The price is predicted to move between $9.96 and $10.39, settling at an average of $10.17. This could translate to a +134.33% gain.
January 2025
Based on current market signals, Lumos Pharma, Inc. is projected to trend january 2025. We forecast a trading range from $10.11 to $17.70, with a likely average price of $13.66. Investors could expect a potential return of +214.75%.
February 2025
Our predictive algorithms indicate Lumos Pharma, Inc. stock may see a shift in February 2025. The expected range spans $15.93–$18.66, with an average target of $17.51. This represents a positive outlook and a possible gain of +303.46%.
March 2025
Analyzing established trends, Lumos Pharma, Inc. looks set to move in March 2025. Projections place the stock between $15.14 and $17.68, averaging around $16.16. This suggests a +272.35% gain from current levels.
April 2025
Market indicators suggest Lumos Pharma, Inc. could experience notable changes during April 2025. Prices could fluctuate within $14.89 to $18.16, with a midpoint forecast of $17.00. The stock might deliver a +291.71% gain.
May 2025
Forecasting for May 2025, models estimate that Lumos Pharma, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $12.94 and $15.81, averaging $14.00. This signals a positive trajectory with potential returns around +222.58%.
June 2025
According to our latest forecast models, Lumos Pharma, Inc. (LUMO) is positioned to show a strong performance in June 2025. The price is predicted to move between $13.93 and $20.40, settling at an average of $16.97. This could translate to a +291.01% gain.
July 2025
Based on current market signals, Lumos Pharma, Inc. is projected to trend july 2025. We forecast a trading range from $15.21 to $20.51, with a likely average price of $17.20. Investors could expect a potential return of +296.31%.
August 2025
Our predictive algorithms indicate Lumos Pharma, Inc. stock may see a shift in August 2025. The expected range spans $15.29–$22.35, with an average target of $17.73. This represents a positive outlook and a possible gain of +308.53%.
September 2025
Analyzing established trends, Lumos Pharma, Inc. looks set to move in September 2025. Projections place the stock between $17.72 and $25.36, averaging around $20.40. This suggests a +370.05% gain from current levels.
October 2025
Market indicators suggest Lumos Pharma, Inc. could experience notable changes during October 2025. Prices could fluctuate within $17.30 to $26.71, with a midpoint forecast of $20.19. The stock might deliver a +365.21% gain.
November 2025
Forecasting for November 2025, models estimate that Lumos Pharma, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $19.42 and $30.04, averaging $22.05. This signals a positive trajectory with potential returns around +408.06%.
December 2025
According to our latest forecast models, Lumos Pharma, Inc. (LUMO) is positioned to show a strong performance in December 2025. The price is predicted to move between $18.09 and $23.99, settling at an average of $19.19. This could translate to a +342.17% gain.
LUMO's history of dividends and stock splits also plays a role in long-term investor confidence.